Lazard Asset Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.07M	Sell	305,224 -23,493	-7%	-$84.5K	﹤0.01%	1137
2025 Q4	$1.12M	Sell	328,717 -323,379	-50%	-$1.44M	﹤0.01%	1118
2025 Q3	$3.28M	Buy	652,096 +142,302	+28%	+$627K	﹤0.01%	707
2025 Q2	$1.75M	Sell	509,794 -323,368	-39%	-$805K	﹤0.01%	1056
2025 Q1	$1.86M	Sell	833,162 -95,432	-10%	-$274K	﹤0.01%	997
2024 Q4	$2.72M	Sell	928,594 -167,981	-15%	-$468K	﹤0.01%	783
2024 Q3	$2.85M	Buy	1,096,575 +4,406	+0.4%	+$12.2K	﹤0.01%	785
2024 Q2	$3.23M	Sell	1,092,169 -927,843	-46%	-$3.51M	﹤0.01%	776
2024 Q1	$9.15M	Sell	2,020,012 -1,391,993	-41%	-$7.1M	0.01%	555
2023 Q4	$19.5M	Buy	3,412,005 +265,172	+8%	+$1.23M	0.02%	391
2023 Q3	$14.5M	Sell	3,146,833 -128,468	-4%	-$782K	0.02%	464
2023 Q2	$21.2M	Buy	3,275,301 +32,102	+1%	+$219K	0.03%	387
2023 Q1	$24.5M	Buy	3,243,199 +336,987	+12%	+$3.06M	0.03%	359
2022 Q4	$29.4M	Sell	2,906,212 -378,810	-12%	-$4.38M	0.04%	319
2022 Q3	$32.5M	Sell	3,285,022 -61,475	-2%	-$674K	0.05%	296
2022 Q2	$35.6M	Buy	3,346,497 +156,660	+5%	+$1.33M	0.05%	296
2022 Q1	$31.1M	Buy	3,189,837 +2,899,091	+997%	+$27.4M	0.04%	366
2021 Q4	$4.16M	Buy	290,746 +149,738	+106%	+$2.27M	﹤0.01%	806
2021 Q3	$2.83M	Buy	+141,008	New	+$2.49M	﹤0.01%	866